Parkinson's disease-associated mutations in the GTPase domain of LRRK2 impair its nucleotide-dependent conformational dynamics.

GTPase Parkinson disease Ras of complex proteins (ROC) conformational change conformational dynamics disease mutation enzyme activation kinase leucine-rich repeat kinase 2 (LRRK2) molecular dynamics

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
12 04 2019
Historique:
received: 18 01 2019
revised: 15 02 2019
pubmed: 24 2 2019
medline: 15 10 2019
entrez: 24 2 2019
Statut: ppublish

Résumé

Mutation in leucine-rich repeat kinase 2 (LRRK2) is a common cause of familial Parkinson's disease (PD). Recently, we showed that a disease-associated mutation R1441H rendered the GTPase domain of LRRK2 catalytically less active and thereby trapping it in a more persistently "on" conformation. However, the mechanism involved and characteristics of this on conformation remained unknown. Here, we report that the Ras of complex protein (ROC) domain of LRRK2 exists in a dynamic dimer-monomer equilibrium that is oppositely driven by GDP and GTP binding. We also observed that the PD-associated mutations at residue 1441 impair this dynamic and shift the conformation of ROC to a GTP-bound-like monomeric conformation. Moreover, we show that residue Arg-1441 is critical for regulating the conformational dynamics of ROC. In summary, our results reveal that the PD-associated substitutions at Arg-1441 of LRRK2 alter monomer-dimer dynamics and thereby trap its GTPase domain in an activated state.

Identifiants

pubmed: 30796162
pii: S0021-9258(20)36663-1
doi: 10.1074/jbc.RA119.007631
pmc: PMC6463707
pii:
doi:

Substances chimiques

Guanosine Diphosphate 146-91-8
Guanosine Triphosphate 86-01-1
LRRK2 protein, human EC 2.7.11.1
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

5907-5913

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM111639
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM111695
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM115844
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM120350
Pays : United States

Références

Neuron. 2004 Nov 18;44(4):595-600
pubmed: 15541308
FASEB J. 2016 Jan;30(1):336-47
pubmed: 26396237
Neuron. 2004 Nov 18;44(4):601-7
pubmed: 15541309
FASEB J. 2019 Apr;33(4):4814-4823
pubmed: 30592623
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2626-31
pubmed: 24510904
Nat Rev Neurosci. 2010 Dec;11(12):791-7
pubmed: 21088684
Hum Mol Genet. 2007 Jan 15;16(2):223-32
pubmed: 17200152
Neurosignals. 2008;16(1):99-105
pubmed: 18097165
EMBO J. 2008 Aug 20;27(16):2239-49
pubmed: 18650931
Trends Neurosci. 2006 May;29(5):286-93
pubmed: 16616379
Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4055-60
pubmed: 24591621
Biochemistry. 2007 Feb 6;46(5):1380-8
pubmed: 17260967
Int J Mol Sci. 2018 Dec 17;19(12):
pubmed: 30562929
J Neurochem. 2007 Oct;103(1):238-47
pubmed: 17623048
Exp Cell Res. 2007 Oct 1;313(16):3658-70
pubmed: 17706965
Nat Commun. 2017 Oct 18;8(1):1008
pubmed: 29044096
Biochim Biophys Acta. 2009 Dec;1792(12):1194-7
pubmed: 19781641
Neurobiol Dis. 2006 Aug;23(2):329-41
pubmed: 16750377
Biochem Biophys Res Commun. 2007 Jun 8;357(3):668-71
pubmed: 17442267
J Biomol Screen. 2001 Dec;6(6):429-40
pubmed: 11788061
Prog Brain Res. 2010;183:115-45
pubmed: 20696318
Genome Biol. 2006;7(5):108
pubmed: 16737558

Auteurs

Chun-Xiang Wu (CX)

From the Departments of Biochemistry and Molecular Biology, Indianapolis, Indiana 46202; The Stark Neurosciences Institute, Indiana University School of Medicine, Indianapolis, Indiana 46202.

Jingling Liao (J)

From the Departments of Biochemistry and Molecular Biology, Indianapolis, Indiana 46202; The Stark Neurosciences Institute, Indiana University School of Medicine, Indianapolis, Indiana 46202; Department of Public Health, Wuhan University of Science and Technology School of Medicine, 430081 Wuhan, China.

Yangshin Park (Y)

From the Departments of Biochemistry and Molecular Biology, Indianapolis, Indiana 46202; The Stark Neurosciences Institute, Indiana University School of Medicine, Indianapolis, Indiana 46202.

Xylena Reed (X)

the Laboratory of Neurogenetics, National Institutes of Health, Bethesda, Maryland 20892.

Victoria A Engel (VA)

From the Departments of Biochemistry and Molecular Biology, Indianapolis, Indiana 46202; The Stark Neurosciences Institute, Indiana University School of Medicine, Indianapolis, Indiana 46202.

Neo C Hoang (NC)

From the Departments of Biochemistry and Molecular Biology, Indianapolis, Indiana 46202; The Stark Neurosciences Institute, Indiana University School of Medicine, Indianapolis, Indiana 46202.

Yuichiro Takagi (Y)

From the Departments of Biochemistry and Molecular Biology, Indianapolis, Indiana 46202.

Steven M Johnson (SM)

From the Departments of Biochemistry and Molecular Biology, Indianapolis, Indiana 46202.

Mu Wang (M)

From the Departments of Biochemistry and Molecular Biology, Indianapolis, Indiana 46202; the Department of Biological Sciences, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu 215123 China.

Mark Federici (M)

ThermoFisher Scientific, Carlsbad, California 92087.

R Jeremy Nichols (RJ)

the Department of Pathology, Stanford University, Stanford, California 94305.

Ruslan Sanishvili (R)

the X-ray Science Division, Argonne National Laboratory, Argonne, Illinois 60439.

Mark R Cookson (MR)

the Laboratory of Neurogenetics, National Institutes of Health, Bethesda, Maryland 20892.

Quyen Q Hoang (QQ)

From the Departments of Biochemistry and Molecular Biology, Indianapolis, Indiana 46202; The Stark Neurosciences Institute, Indiana University School of Medicine, Indianapolis, Indiana 46202; Department of Neurology, Indiana University School of Medicine, Indianapolis, Indiana 46202. Electronic address: qqhoang@iu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH